BillionToOne Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 510

Employees

  • Latest Deal Type
  • Debt Refin.

  • Latest Deal Amount
  • $140M

  • Investors
  • 44

BillionToOne General Information

Description

Developer of a molecular diagnostics company intended to develop prenatal and oncology assays that are at the physical limit of sensitivity and precision. The company offers an ultrasensitive comprehensive genomic profiling assay that detects more actionable mutations for therapy selection and a pan-cancer tumor-naive oncology test that precisely quantifies tumor burden from a blood sample to track response to therapy and prenatal tests go beyond aneuploidies to detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a simple blood test.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1035 O'Brien Drive
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Corporate Office
  • 1035 O'Brien Drive
  • Menlo Park, CA 94025
  • United States
+1 (650)

BillionToOne Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BillionToOne Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Debt Refinancing 04-Sep-2024 $140M Completed Generating Revenue
10. Later Stage VC (Series D) 07-May-2024 Completed Generating Revenue
9. Secondary Transaction - Private Completed Generating Revenue
8. Later Stage VC 15-Dec-2022 Completed Generating Revenue
7. Later Stage VC (Series C) 16-Mar-2022 Completed Generating Revenue
6. Later Stage VC (Series B) 14-Jun-2021 Completed Generating Revenue
5. Later Stage VC (Series A) 22-Feb-2021 Completed Generating Revenue
4. Grant 01-Jan-2018 Completed Generating Revenue
3. Seed Round 30-Sep-2017 $2.5M $2.5M Completed Generating Revenue
2. Accelerator/Incubator 22-Aug-2017 Completed Startup
To view BillionToOne’s complete valuation and funding history, request access »

BillionToOne Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B-2
Series B-1
Series A-6
Series A-5
Series A-4
Series A-3
Series A-2 1,137,210 $0.000010 $0.8 $0.8 1x $0.8 3.05%
Series A-1 1,349,650 $0.000010 $0.4 $0.4 1x $0.4 3.62%
To view BillionToOne’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BillionToOne Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular diagnostics company intended to develop prenatal and oncology assays that are at the physical l
Diagnostic Equipment
Menlo Park, CA
510 As of 2025

Cambridge, MA
 

Austin, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BillionToOne Competitors (6)

One of BillionToOne’s 6 competitors is Foundation Medicine, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Formerly VC-backed Cambridge, MA
Natera Formerly VC-backed Austin, TX
Myriad Genetics Corporation Salt Lake City, UT
Guardant Health Formerly VC-backed Palo Alto, CA
Tempus AI Formerly VC-backed Chicago, IL
To view BillionToOne’s complete competitors history, request access »

BillionToOne Patents

BillionToOne Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230295741-A1 Molecule counting of methylated cell-free dna for treatment monitoring Active 21-Mar-2022
US-12043873-B2 Molecule counting of methylated cell-free dna for treatment monitoring Active 21-Mar-2022
AU-2023240345-A1 Molecule counting of methylated cell-free dna for treatment monitoring Pending 21-Mar-2022
EP-4496900-A2 Molecule counting of methylated cell-free dna for treatment monitoring Pending 21-Mar-2022
US-20240360519-A1 Molecule counting of methylated cell-free dna for treatment monitoring Pending 21-Mar-2022 C12Q1/6827
To view BillionToOne’s complete patent history, request access »

BillionToOne Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BillionToOne Investors (44)

Investor Name Investor Type Holding Investor Since Participating Rounds
Neuberger Berman Asset Manager Minority
NYX Ventures Partners Venture Capital Minority
Premji Invest (US) Growth/Expansion Minority
Brightway Future Capital Venture Capital Minority
Eczacıbaşı Momentum Corporate Venture Capital Minority
You’re viewing 5 of 44 investors. Get the full list »

BillionToOne FAQs

  • When was BillionToOne founded?

    BillionToOne was founded in 2016.

  • Where is BillionToOne headquartered?

    BillionToOne is headquartered in Menlo Park, CA.

  • What is the size of BillionToOne?

    BillionToOne has 510 total employees.

  • What industry is BillionToOne in?

    BillionToOne’s primary industry is Diagnostic Equipment.

  • Is BillionToOne a private or public company?

    BillionToOne is a Private company.

  • What is BillionToOne’s current revenue?

    The current revenue for BillionToOne is .

  • How much funding has BillionToOne raised over time?

    BillionToOne has raised $551M.

  • Who are BillionToOne’s investors?

    Neuberger Berman, NYX Ventures Partners, Premji Invest (US), Brightway Future Capital, and Eczacıbaşı Momentum are 5 of 44 investors who have invested in BillionToOne.

  • Who are BillionToOne’s competitors?

    Foundation Medicine, Natera, Myriad Genetics, Guardant Health, and Tempus AI are some of the 6 competitors of BillionToOne.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »